| Zustovich, Fable |
| Recruiting | 4 | 175 | Europe | PAXG regimen (cisplatin, nab-paclitaxel, capecitabine, gemcitabine) chemotherapy | IRCCS San Raffaele | Pancreatic Ductal Adenocarcinoma | 01/22 | 01/26 | | |
FIL_FOLL19, NCT05058404: Shortened vs Standard Chemotherapy Combined With Immunotherapy for the Initial Treatment of Patients With High Tumor Burden Follicular Lymphoma |
|
|
| Recruiting | 3 | 602 | Europe | Immunochemotherapy regimen: Rituximab-bendamustine (Arm A), R-Benda, R-bendamustine, Immunochemotherapy regimen: Rituximab-bendamustine (Arm B), Immunochemotherapy regimen: R-CHOP (Arm A), R-CHOP, Immunochemotherapy regimen: R-CHOP (Arm B), Immunochemotherapy regimen: G-bendamustine (Arm A), G-Benda, Immunochemotherapy regimen: G-bendamustine (Arm B), Immunochemotherapy regimen: G-CHOP (Arm A), G-CHOP, Immunochemotherapy regimen: G-CHOP (Arm B), Immunochemotherapy regimen: G-CVP (Arm A), G-CVP, Immunochemotherapy regimen: G-CVP (Arm B) | Fondazione Italiana Linfomi - ETS | Follicular Lymphoma | 07/28 | 07/30 | | |
| Recruiting | 3 | 132 | Europe | Letrozole tablets, carboplatin AUC 5 and paclitaxel 175 mg/m2 | Ente Ospedaliero Ospedali Galliera, Istituto Di Ricerche Farmacologiche Mario Negri, Humanitas Hospital, Italy | Carcinoma, Ovarian Epithelial, Low Grade Serous Adenocarcinoma of Ovary | 09/29 | 09/29 | | |
HERMIONE-7, NCT04227327: Study Evaluating Abemaciclib + Aromatase Inhibitors in HR+, HER2- Advanced Breast Cancer Patients |
|
|
| Active, not recruiting | 2 | 31 | Europe | Abemaciclib, Aromatase Inhibitors | University of Milano Bicocca | Advanced Breast Cancer | 12/23 | 12/23 | | |
NCT04811781: Epidemiological Features and Clinical Course of COVID -19 Infection in Cancer Patients: The Rovid Study |
|
|
| Completed | N/A | 761 | Europe | | Istituto Oncologico Veneto IRCCS | Solid Tumor, Adult | 06/21 | 06/21 | | |
HERMIONE-13, NCT05173103: Retrospective Study of 2nd-line Therapies After CDK4/6i + Hormonal Therapy in HR+/HER2- Advanced Breast Cancer |
|
|
| Recruiting | N/A | 150 | Europe | | University of Milano Bicocca | Advanced Breast Cancer, Hormone Receptor Positive Breast Carcinoma, HER2-negative Breast Cancer | 01/24 | 01/24 | | |
NCT04810182: Regorafenib in Patients With Relapsed Glioblastoma. IOV-GB-1-2020 REGOMA-OSS |
|
|
| Completed | N/A | 192 | Europe | Regorafenib 40 MG Oral Tablet [STIVARGA] | Istituto Oncologico Veneto IRCCS | Glioblastoma Multiforme | 12/23 | 12/23 | | |
NCT05934084: Lifestyles Implemented-Survivorship Care Plan In Lymphoma Survivors |
|
|
| Recruiting | N/A | 552 | Europe | Lifestyles Implemented-Survivorship Care Plan (LS-SCP) | Fondazione Italiana Linfomi - ETS | Classical Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma (DLBCL), Primary Mediastinal Large B-cell Lymphoma (PMBCL) | 02/26 | 02/26 | | |
